Insight Medbotics
When accuracy and precision matter most
When accuracy and precision matter most
Insight Medbotics is a Canada-based startup founded in 2017, specializing in the development of MRI-guided robotics with the aim to combine the unique insights provided by MRI with the minimally invasive access and precision of robotics. Their flagship product, the MRI-compatible robot IGAR, has been clinically demonstrated in breast cancer patients, showcasing its potential for biopsy, targeted therapy delivery, and device placement. The company's slogan "When accuracy and precision matter most" reflects their focus on delivering advanced MRI-guided robotic technology to enhance accuracy and precision in medical procedures. Recently, the company secured a noteworthy $435.00K Seed Round investment on 20 April 2022 from the McMaster Seed Fund (MSF). Insight Medbotics is positioned at the intersection of Biopharma, Biotechnology, and Health Care industries, aiming to impact patients, physicians, and hospitals where accuracy and precision are of paramount importance.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | $435.00K | 1 | McMaster Seed Fund (MSF) | 20 Apr 2022 |
No recent news or press coverage available for Insight Medbotics.
We care about your data, and we'd love to use cookies make your experience better.
